Senseonics Holdings, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 at 4:30 p.m. Eastern Time

Rhea-AI Summary

Senseonics Holdings, Inc. (NYSE-American: SENS) will release its second quarter 2023 financial results after market close on August 10, 2023. The company is focused on developing long-term implantable continuous glucose monitoring systems for people with diabetes. A conference call to review performance will be held at 4:30 p.m. (Eastern Time) on the same day, with a webcast available on the company's website.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its second quarter 2023 financial results after market close on Thursday, August 10, 2023.

Management will hold a conference call to review the Company’s second quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061 (International), passcode 2402364, approximately ten to five minutes prior to start time.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense®, Eversense® XL and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230727213186/en/

INVESTOR CONTACT

Philip Taylor

Gilmartin Group

415-937-5406

investors@senseonics.com

Source: Senseonics Holdings, Inc.

FAQ

When will Senseonics Holdings, Inc. release its second quarter 2023 financial results?

Senseonics Holdings, Inc. will release its second quarter 2023 financial results after market close on Thursday, August 10, 2023.

What is the focus of Senseonics Holdings, Inc.?

Senseonics Holdings, Inc. is focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes.

How can I listen to the conference call to review Senseonics Holdings, Inc.'s second quarter 2023 performance?

To listen to the conference call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061 (International), passcode 2402364, approximately ten to five minutes prior to start time. The webcast will also be available on the company's website at www.senseonics.com under 'Investor Relations' and 'Events & Publications', and will be archived there for future reference.